Organization name
Haematology
Alternate names
Haematology
Country
Afghanistan


Results 1-52 of 52 (Search time: 0.0 seconds).

PreviewIssue DateTitleAuthor(s)
122-Nov-2023Variability of bone marrow biopsy reporting affects accuracy of diagnosis of myeloproliferative neoplasms: data from the ALLG MPN01 registryNg, Wei YangErber, Wendy NGrigg, AndrewDunne, KarinPerkins, AndrewForsyth, Cecily Ross, David M
2May-2017Upfront lower dose lenalidomide is less toxic and does not compromise efficacy for vulnerable patients with relapsed refractory multiple myeloma: final analysis of the phase II RevLite studyForsyth, Cecily J Quach, H.Fernyhough, L.Henderson, R.Corbett, G.Baker, B.Browett, P.Blacklock, H.Underhill, C.Cannell, P.Trotman, J.Neylon, A.Harrison, S.Link, E.Swern, A.Cowan, L.Dimopoulos, M.A.Miles Prince, H.
3Feb-2020Two monogenic disorders masquerading as one: severe congenital neutropenia with monocytosis and non-syndromic sensorineural hearing lossForsyth, Cecily J Venugopal, P.Gagliardi, L.Feng, J.Phillips, K.Babic, M.Poplawski, N.K.Rienhoff, H.Y.,Jr.Schreiber, A.W.Hahn, C.N.Brown, A.L.Scott, H.S.
41991Treatment of acute graft versus host disease with a murine monoclonal antibody to the IL-2 receptorTiley, Campbell Powles, R.Teo, C.P.Treleaven, J.Findlay, M.Hewetson, M.
57-Dec-2023Sorafenib plus intensive chemotherapy in newly diagnosed FLT3-ITD AML: a randomized, placebo-controlled study by the ALLGLoo, SunRoberts, Andrew WAnstee, Natasha SKennedy, Glen AHe, SimonSchwarer, Anthony PEnjeti, Anoop KD'Rozario, JamesMarlton, PaulaBilmon, Ian ATaper, JohnCull, GavinTiley, Campbell Verner, EmmaHahn, UweHiwase, Devendra KIland, Harry JMurphy, NickRamanathan, SundraReynolds, JohnOng, Doen MingTiong, Ing SooWall, MeaghanMurray, MichaelRawling, TristanLeadbetter, JoannaRowley, LeesaLatimer, MayaYuen, SamTing, Stephen BFong, Chun YewMorris, KirkBajel, AshishSeymour, John FLevis, Mark JWei, Andrew H
65-Jul-2023Somatic mutational landscape of hereditary hematopoietic malignancies caused by germ line RUNX1, GATA2, and DDX41 variantsHoman, Claire CDrazer, Michael WYu, KaiLawrence, David MichaelFeng, JinghuaArriola-Martinez, Luis AlbertoPozsgai, Matthew JMcNeely, Kelsey EHa, Thuong ThiVenugopal, ParvathyArts, PeerKing-Smith, SarahCheah, Jesse JcArmstrong, MarkWang, PaulBödör, CsabaCantor, Alan BCazzola, MarioDegelman, Erin SDiNardo, Courtney DDuployez, NicolasFavier, RémiFröhling, StefanRio-Machin, AnaKlco, Jeffery MKrämer, AlwinKurokawa, MineoLee, JoanneMalcovati, LucaMorgan, Neil VGeorges, NatsoulisOwen, CarolynPatel, Keyur PPreudhomme, ClaudeRaslova, HanaRienhoff, Hugh YoungRipperger, TimSchulte, Rachael RTawana, KiranVelloso, ElviraBenedict, YanKim, Erika Mijin KwonSood, RamanHsu, Amy PHolland, Steven MPhillips, KerryPoplawski, NicolaBabic, MilenaWei, Andrew HForsyth, Cecily J Mar Fan, HelenLewis, IanCooney, Julian PSusman, RachelFox, Lucy CBlombery, PiersSinghal, DeepakHiwase, Devendra KPhipson, BelindaSchreiber, Andreas WHahn, Christopher NScott, Hamish SLiu, Paul PGodley, Lucy ABrown, Anna L
7May-2017Raccoon eyes in systemic light chain amyloidosisForsyth, Cecily J Tiley, Campbell 
8Jul-2021Proteasome inhibitor-induced coronary vasospasm in multiple myeloma: A case reportRogers, James Forsyth, Cecily J Ford, Tom Mikhail, Philopatir 
913-Oct-2023A population-based family case-control study of sun exposure and follicular lymphoma riskOdutola, Michael Kvan Leeuwen, Marina TBruinsma, FionaTurner, JenniferHertzberg, MarkSeymour, John FPrince, H MilesTrotman, JudithVerner, EmmaRoncolato, FernandoOpat, StephenLindeman, RobertTiley, Campbell Milliken, Samuel TUnderhill, Craig RBenke, GezaGiles, Graham GVajdic, Claire M
101-Mar-2024Phase II trials of zilucoplan in paroxysmal nocturnal hemoglobinuriaKulasekararaj, Austin GLehtinen, Anna-ElinaForsyth, Cecily Gandhi, ShreyansGriffin, MoragKörper, SixtenMikala, GaborMuus, PetraOvergaard, UlrikPatriquin, Christopher JPullon, HumphreyShen, Yu-MinSpearing, RuthSzer, JeffDe la Borderie, GuillemetteDuda, Petra WFarzaneh-Far, RaminRagunathan, SharanSayegh, Camil EVadysirisack, Douangsone DSchrezenmeier, Hubert
1114-Jun-2022Paraprotein associated heparin resistance during cardiopulmonary bypassKhuong, Jacqueline NForsyth, Cecily J Manuel, LucyKingsford-Smith, KateSrivastava, ArpitBassin, Levi
125-Mar-2023Painless progressive mononeuritis multiplex secondary to AML associated neuroleukemiosisNagaratnam, Sai Harinesan, NimalanWijesinghe, RajivWong-Doo, NicoleLyons, Alison Morris, KatrinaTriplett, James 
13Sep-2019Outpatient rituximab, ifosfamide, etoposide (R-IE) in patients older than 60 years with relapsed or refractory diffuse large B-cell lymphoma who are not candidates for stem cell transplantationForsyth, Cecily J Joshi, M.Taper, J.Rowlings, P.Campbell, P.Crispin, P.Harvey, M.Underhill, C.Bayley, A.Byth, K.Huang, G.Hertzberg, M.
14Oct-2023Occupational exposure to extremely low-frequency magnetic fields and follicular lymphoma risk: a family case-control studyOdutola, Michael Kvan Leeuwen, Marina TBruinsma, Fiona JBenke, GezaTurner, Michelle CTrotman, JudithTurner, JenniferSeymour, John FPrince, H MilesMilliken, Samuel TTiley, Campbell Hertzberg, MarkRoncolato, FernandoOpat, StephenLindeman, RobertVerner, EmmaUnderhill, Craig RCardis, ElisabethGiles, GrahamVajdic, Claire M
15Nov-2009New agents for orthopaedic thromboprophylaxis: caution essential, but time will tellVerma, Abhishek K 
16Apr-2019The natural history of vascular and other complications in patients treated with nilotinib for chronic myeloid leukemiaForsyth, Cecily J Minson, A.G.Cummins, K.Fox, L.Costello, B.Yeung, D.Cleary, R.Tatarczuch, M.Burbury, K.Motorna, O.Shortt, J.Fleming, S.McQuillan, A.Schwarer, A.Harrup, R.Holmes, A.Ratnasingam, S.Chan, K.L.Hsu, W.H.Ashraf, A.Putt, F.Grigg, A.
17Dec-2019A multi-center randomized controlled trial to reduce unmet needs, depression, and anxiety among hematological cancer patients and their support personsTiley, Campbell Stevenson, W.Bryant, J.Watson, R.Sanson-Fisher, R.Oldmeadow, C.Henskens, F.Brown, C.Ramanathan, S.Enjeti, A.Guest, J.Tzelepis, F.Paul, C.D'Este, C.
18Oct-2021An MRD-stratified pediatric protocol is as deliverable in adolescents and young adults as children with ALLWylie, Brenton Greenwood, M.Trahair, T.Sutton, R.Osborn, M.P.Kwan, J.Mapp, S.Howman, R.Anazodo, A.D'Rozario, J.Hertzberg, M.Irving, I.Yeung, D.T.Coyle, L.Jager, A.Engeler, D.M.Venn, N.C.Frampton, C.Wei, A.H.Bradstock, K.F.Dalla-Pozza, L.
1929-Jun-2022Monoclonal B-cell Lymphocytosis - a review of diagnostic criteria, biology, natural history, and clinical managementTang, Catherine Shen, YandongSoosapilla, AshaMulligan, Stephen P
20Sep-2020Melphalan exposure and outcome in obese and non-obese adults with myeloma. A study of pharmacokinetics and pharmacodynamicsTiley, Campbell Nath, C.E.Trotman, J.Nivison-Smith, I.Gurney, H.Zeng, L.Presgrave, P.Joshua, D.Kerridge, Ian McLachlan, Andrew Shaw, P.J.
21Jan-2020Intensive chemotherapy and up-front stem cell transplant for double hit lymphomaArmytage, Tasman Othman, J.Wong, K.Arthur, C.Fay, K.Stevenson, W.MacKinlay, N.Ward, C.Pechey, V.Coyle, L.Kerridge, Ian Greenwood, M.
22May-2017The incidence and natural history of dasatinib complications in the treatment of chronic myeloid leukemiaForsyth, Cecily J Fox, L.Cummins, K.D.Costello, B.Yeung, D.Cleary, R.Tatarczuch, M.Burbury, K.Motorna, O.Shortt, J.Fleming, S.McQuillan, A.Schwarer, A.Harrup, R.Holmes, A.Ratnasingam, S.Chan, K.L.Hsu, W.H.Ashraf, A.Putt, F.Grigg, A.
23Jun-2023Immunochemotherapy for life-threatening haematological malignancies in pregnancy: a systematic review of the literature and cross-sectional analysis of clinical trial eligibilityMills, Georgia SChadwick, VerityTang, Catherine Perram, JacintaAnderson, Mary AnnAnazodo, AntoinetteKidson-Gerber, GiselleShand, AntoniaLavee, OrlyWithers, BarbaraMilliken, SamDi Ciaccio, Pietro RHamad, Nada
24May-2017Idarubicin dose escalation during consolidation therapy for adult Acute Myeloid LeukemiaTiley, Campbell Bradstock, K.F.Link, E.Di Iulio, J.Szer, J.Marlton, P.Wei, A.H.Enno, A.Schwarer, A.Lewis, I.D.D'Rozario, J.Coyle, L.Cull, G.Campbell, P.Leahy, M.F.Hahn, U.Cannell, P.Lowenthal, R.M.Moore, J.Cartwright, K.Cunningham, I.Taper, J.Grigg, A.Roberts, A.W.Benson, W.Hertzberg, M.Deveridge, S.Rowlings, P.Mills, A.K.Gill, Devinder S Bardy, P.Campbell, L.J.Seymour, J.F.
25Apr-2018Humoral immune failure defined by immunoglobulin class and immunoglobulin G subclass deficiency is associated with shorter treatment-free and overall survival in Chronic Lymphocytic LeukaemiaForsyth, Cecily J Crassini, K.R.Zhang, E.Balendran, S.Freeman, J.A.Best, O.G.Mackinlay, N.J.Han, P.Stevenson, W.S.Mulligan, S.P.
2626-Mar-2024How comparable are patient outcomes in the "real-world" with populations studied in pivotal AML trials?Tiong, Ing SooWall, MeaghanBajel, AshishKalro, AkashFleming, ShaunRoberts, Andrew WThiagarajah, NishaChua, Chong ChynLatimer, MayaYeung, DavidMarlton, PaulaJohnston, AmandaEnjeti, AnoopFong, Chun YewCull, GavinLarsen, StephenKennedy, GlenSchwarer, AnthonyKipp, DavidRamanathan, SundraVerner, EmmaTiley, Campbell Morris, EdwardHahn, UweMoore, JohnTaper, JohnPurtill, DuncanWarburton, PaulineStevenson, WilliamMurphy, Nicholas J Tan, PeterBeligaswatte, AshankaMutsando, HowardHertzberg, MarkShortt, JakeSzabo, FerencDunne, KarinWei, Andrew H
27Jul-2016High melphalan exposure is associated with improved overall survival in myeloma patients receiving high dose melphalan and autologous transplantationTiley, Campbell Nath, C.E.Trotman, J.Presgrave, P.Joshua, D.Kerridge, Ian Kwan, Y.L.Gurney, H.McLachlan, Andrew Earl, J.W.Nivison-Smith, I.Zeng, L.Shaw, P.J.
28Jan-2019Hereditary haemorrhagic telangiectasiaForsyth, Cecily J Mangkorntongsakul, Varitsara 
29Oct-2020Efficacy and Safety of ABP 798: Results from the JASMINE Trial in Patients with Follicular Lymphoma in Comparison with Rituximab Reference ProductForsyth, Cecily J Niederwieser, D.Hamm, C.Cobb, P.Mo, M.Tucci, A.Hanes, V.Delwail, V.Hajek, R.Chien, D.
30Apr-2009The direct factor Xa inhibitor rivaroxabanVerma, Abhishek K 
3116-Sep-2021Diffuse large B-cell lymphoma: A consensus practice statement from the Australasian Lymphoma AllianceArmytage, Tasman Wight, J.Hamad, N.Campbell, B. A.Ku, M.Lee, K.Rose, H.Latimer, M.Lee, H. P.Lee, S. T.Dickinson, M.Khor, R.Verner, E.
32Jan-2023Dietary intake of animal-based products and likelihood of follicular lymphoma and survival: A population-based family case-control studyOdutola, Michael Kvan Leeuwen, Marina TBassett, Julie KBruinsma, FionaTurner, JenniferSeymour, John FPrince, Henry MilesMilliken, Samuel THertzberg, MarkRoncolato, FernandoOpat, Stephen SLindeman, RobertTiley, Campbell Trotman, JudithVerner, EmmaHarvey, MichaelUnderhill, Craig RBenke, GezaGiles, Graham GVajdic, Claire M
33Jan-2018Delayed-onset heparin-induced thrombocytopenia complicated by arterial and venous thrombosesForsyth, Cecily J HarrisonBalendran, S.Harrison, A.Morel-Kopp, M. C.Ward, C.
34Dec-2018The delayed diagnosis of myeloproliferative neoplasms is common and results in a high incidence of potentially preventable thrombotic complicationsForsyth, Cecily J Melville, K.Tiley, Campbell 
35Apr-2020Cutaneous multiple myelomaForsyth, Cecily J Jagger, Jacqueline Lai, S.
36May-2021COVID-19 vaccination in haematology patients: an Australian and New Zealand consensus position statementArmytage, Tasman McCaughan, G.Di Ciaccio, P.Ananda-Rajah, M.Gilroy, N.MacIntyre, R.Teh, B.Weinkove, R.Curnow, J.Szer, J.Enjeti, A.K.Ross, D.M.Mulligan, S.Trotman, J.Dickinson, M.Quach, H.Choi, P.Polizzotto, M.N.Tam, C.S.Ho, P.J.Ku, M.Gregory, G.Gangatharan, S.Hapgood, G.Cochrane, T.Cheah, C.Gibbs, S.Wei, A.Johnston, A.Greenwood, M.Prince, H.M.Latimer, M.Berkahn, L.Wight, J.Hamad, N.
37Aug-2016Correlation of blood counts with vascular complications in essential thrombocythemia: analysis of the prospective PT1 cohortForsyth, Cecily J Campbell, P.J.MacLean, C.Beer, P.A.Buck, G.Wheatley, K.Kiladjian, J.J.Harrison, C.N.Green, A.R.
38Feb-2017Clinicopathological differences exist between CALR- and JAK2-mutated myeloproliferative neoplasms despite a similar molecular landscape: data from targeted next-generation sequencing in the diagnostic laboratory.Forsyth, Cecily J Agarwal, R.Blombery, P.McBean, M.Jones, K.Fellowes, A.Doig, K.Westerman, D.A.
397-Mar-2023The clinical features, management and outcomes of lymphoma in pregnancy: A multicentre study by the Australasian Lymphoma AllianceDi Ciaccio, Pietro RMills, GeorgiaShipton, Michael JCampbell, BelindaGregory, GarethLangfield, JennaGreenwood, MatthewMcKeague, SeanShanavas, MohammadEslick, ReneeKidson-Gerber, GiselleSmallbone, PortiaTang, Catherine Morris, KirkBilmon, IanYannakou, CostasBadoux, XavierBerkahn, LeanneFarina, SergioMason, Kylie DMotum, PenelopeGoss, KathrynHamad, Nada
4020-Dec-2022Clinical characteristics of Australian treatment-naïve patients with classical Hodgkin lymphoma from the lymphoma and related diseases registryNguyen, JamesWellard, CameronChung, ElizaCheah, Chan YDickinson, MichaelDoo, Nicole WongKeane, ColmTalaulikar, DiptiBerkahn, LeanneMorgan, SusanHamad, NadaCochrane, TaraJohnston, Anna MForsyth, Cecily J Opat, StephenBarraclough, AllisonMutsando, HowardRatnasingam, SumitaGiri, PratyushWood, Erica MMcQuilten, Zoe KHawkes, Eliza A
41Apr-2019Changing incidence of myeloproliferative neoplasms in Australia, 2003-2014Forsyth, Cecily J Baade, P.D.Ross, D.M.Anderson, L.A.Fritschi, L.
427-Oct-2022Challenges associated with test dose pharmacokinetic predictions of high dose melphalan exposure in patients with multiple myelomaNath, Christa EllenGrigg, AndrewRosser, Sebastian P AEstell, JaneNewman, ElizabethTiley, Campbell Ramanathan, SundraHo, Shir JingLarsen, StephenGibson, JohnPresgrave, Peter Shaw, Peter JohnTrotman, Judith
43Mar-2017A case-based discussion of clinical problems in the management of patients treated with ruxolitinib for myelofibrosisForsyth, Cecily J Ho, P.J.Bajel, A.Burbury, K.Dunlop, L.Durrant, S.Perkins, A.C.Ross, D.M.
4424-Nov-2022Capturing the lived experiences of women with lymphoma in pregnancy: a qualitative studyMills, Georgia SDi Ciaccio, Pietro RTang, Catherine Chadwick, VerityMason, Kylie DCampbell, Belinda AShipton, Michael JShanavas, MohamedMorris, Kirk LGreenwood, MatthewLangfield, JennaKidson-Gerber, GiselleEslick, ReneeBadoux, XavierYannakou, Costas KGangatharan, Shane ABilmon, IanHamad, Nada
45Jan-2017Busulfan is effective second-line therapy for older patients with Philadelphia-negative myeloproliferative neoplasms intolerant of or unresponsive to hydroxyureaForsyth, Cecily J Douglas, G.Harrison, C.N.Bennett, M.Stevenson, W.S.Hounsell, J.Ratnasingam, S.Ritchie, D.Ross, D.M.Grigg, A.
46Feb-2023Australian experience with ibrutinib in patients with relapsed/refractory mantle cell lymphoma: a study from the Lymphoma and Related Diseases RegistryBaggio, DivaWellard, CameronChung, ElizaTalaulikar, DiptiKeane, ColmOpat, StephenGiri, PratyushMinson, AdrianCheah, Chan YoonArmytage, Tasman Lee, DeniseChong, GeoffreyJohnston, AnnaCochrane, TaraWaters, NeilHamad, NadaWood, Erica MHawkes, Eliza A
47May-2020Australian and New Zealand consensus statement on the management of lymphoma, chronic lymphocytic leukaemia and myeloma during the COVID-19 pandemicArmytage, Tasman Di Ciaccio, P.McCaughan, G.Trotman, J.Ho, P.J.Cheah, C.Y.Gangatharan, S.Wight, J.Ku, M.Quach, H.Gasiorowski, R.Polizzotto, M.N.Prince, H.M.Mulligan, S.Tam, C.S.Gregory, G.Hapgood, G.Spencer, A.Dickinson, M.Latimer, M.Johnston, A.Lee, C.Cochrane, T.Berkahn, L.Weinkove, R.Doocey, R.Harrison, H.J.Webber, N.Lee, H.P.Chapman, S.Campbell, B.A.Gibbs, S.D.J.Hamad, N.
48Aug-2021Australia and New Zealand Transplant and Cellular Therapies COVID-19 vaccination consensus position statementTiley, Campbell Hamad, N.Ananda-Rajah, M.Gilroy, N.MacIntyre, R.Gottlieb, D.Ritchie, D.Harrison, S.Kennedy, G.Watson, A.M.Greenwood, M.Doocey, R.Perera, T.Spencer, A.Wong, E.O'Brien, T.Shaw, P.Conyers, R.Milliken, S.Bardy, P.Larsen, S.Ho, P.J.Lai, H.Bajel, A.Butler, J.D'Rozario, J.Johnston, A.Cochrane, T.Mills, T.Irving, I.Pullon, H.Purtill, D.
49Feb-2024Australia and New Zealand consensus position statement: use of COVID-19 therapeutics in patients with haematological malignanciesCampbell, AshleaTeh, BenjaminMulligan, StephenRoss, David MWeinkove, RobertGilroy, NicoleGangatharan, ShanePrince, Henry MilesSzer, JeffTrotman, JudithLane, StevenDickinson, MichaelQuach, HangEnjeti, Anoop KKu, MatthewGregory, GarethHapgood, GregoryHo, Phoebe JoyCochrane, TaraCheah, ChanGreenwood, MatthewLatimer, MayaBerkahn, LeanneWight, JoelArmytage, Tasman Diamond, PeterTam, Constantine SHamad, Nada
5030-May-2022Associations between Smoking and Alcohol and Follicular Lymphoma Incidence and Survival: A Family-Based Case-Control Study in AustraliaOdutola, Michael Kvan Leeuwen, Marina TTurner, JenniferBruinsma, FionaSeymour, John FPrince, Henry MMilliken, Samuel TTrotman, JudithVerner, EmmaTiley, Campbell Roncolato, FernandoUnderhill, Craig ROpat, Stephen SHarvey, MichaelHertzberg, MarkBenke, GezaGiles, Graham GVajdic, Claire M
5110-Jan-2024Arsenic-induced neurotoxicity in patients with acute promyelocytic leukaemiaLoh, ZoeAshby, MichaelVan Veldhuizen, EllieLi, WenlongChee, AshlynAung, WinpaLavrukhina, YelenaMason, GeorgePelly, TenilleNedumannil, RithinKosciejew, SerenaMokoonlall, MridulaLim, JonathanCalov, GeorginaButler, LlewynHillebrand, PaulinaBeekman, AshleyRathnasekara, Greasha KalaniRaj, SoniaZhang, CatheyYao, Yao Iland, HarryGrigg, Andrew
5230-Dec-2022Acute myeloid leukaemia with NPM1 mutation: no longer having an absolute blast (count)Zhang, Lucy Campion, VictoriaDickson, MichelleTang, Catherine 

OrgUnit's Researchers publications
(Dept/Workgroup Publication)

Results 1-83 of 83 (Search time: 0.002 seconds).

PreviewIssue DateTitleAuthor(s)
1Oct-2001Abnormal dicentric chromosome with co-amplification of sequences from chromosomes 11 and 19: a novel rearrangement in a patient with myelodysplastic syndrome transforming to acute myeloid leukemiaForsyth, Cecily J Smith, A.Heaps, L.S.Sharma, P.Jarvis, A.
230-Dec-2022Acute myeloid leukaemia with NPM1 mutation: no longer having an absolute blast (count)Zhang, Lucy Campion, VictoriaDickson, MichelleTang, Catherine 
3Aug-2012All-Trans-Retinoic Acid, Idarubicin, and IV Arsenic Trioxide as initial therapy in Acute Promyelocytic Leukemia (APML4)Iland, H.J.Bradstock, K.F.Supple, S.G.Catalano, A.Collins, M.Hertzberg, M.Browett, P.Grigg, A.Firkin, F.Hugman, A.Reynolds, J.Di Iulio, J.Tiley, Campbell Taylor, K.Filshie, R.Seldon, M.Taper, J.Szer, J.Moore, J.Bashford, J.Seymour, J.F.
4Jun-2015Are Australian clinicians monitoring medication adherence in hematological cancer survivors? Two cross-sectional studiesTiley, Campbell Lynagh, M.C.Clinton-McHarg, T.Hall, A.Sanson-Fisher, R.Stevenson, W.Bisquera, A.
510-Jan-2024Arsenic-induced neurotoxicity in patients with acute promyelocytic leukaemiaLoh, ZoeAshby, MichaelVan Veldhuizen, EllieLi, WenlongChee, AshlynAung, WinpaLavrukhina, YelenaMason, GeorgePelly, TenilleNedumannil, RithinKosciejew, SerenaMokoonlall, MridulaLim, JonathanCalov, GeorginaButler, LlewynHillebrand, PaulinaBeekman, AshleyRathnasekara, Greasha KalaniRaj, SoniaZhang, CatheyYao, Yao Iland, HarryGrigg, Andrew
6Oct-2022Associations between early-life growth pattern and body size and follicular lymphoma risk and survival: a family-based case-control studyOdutola, Michael Kvan Leeuwen, Marina TTurner, JenniferBruinsma, FionaSeymour, John FPrince, H MilesMilliken, Samuel THertzberg, MarkTrotman, JudithOpat, Stephen SLindeman, RobertRoncolato, FernandoVerner, EmmaHarvey, MichaelTiley, Campbell Underhill, Craig RBenke, GezaGiles, Graham GVajdic, Claire M
730-May-2022Associations between Smoking and Alcohol and Follicular Lymphoma Incidence and Survival: A Family-Based Case-Control Study in AustraliaOdutola, Michael Kvan Leeuwen, Marina TTurner, JenniferBruinsma, FionaSeymour, John FPrince, Henry MMilliken, Samuel TTrotman, JudithVerner, EmmaTiley, Campbell Roncolato, FernandoUnderhill, Craig ROpat, Stephen SHarvey, MichaelHertzberg, MarkBenke, GezaGiles, Graham GVajdic, Claire M
8Aug-2021Australia and New Zealand Transplant and Cellular Therapies COVID-19 vaccination consensus position statementTiley, Campbell Hamad, N.Ananda-Rajah, M.Gilroy, N.MacIntyre, R.Gottlieb, D.Ritchie, D.Harrison, S.Kennedy, G.Watson, A.M.Greenwood, M.Doocey, R.Perera, T.Spencer, A.Wong, E.O'Brien, T.Shaw, P.Conyers, R.Milliken, S.Bardy, P.Larsen, S.Ho, P.J.Lai, H.Bajel, A.Butler, J.D'Rozario, J.Johnston, A.Cochrane, T.Mills, T.Irving, I.Pullon, H.Purtill, D.
9Mar-1996Autologous red cell recovery and relapse of multiple myeloma after bone marrow transplantation: is this a graft-versus-myeloma effect?Forsyth, Cecily J Nelson, M.Popp, H.Snowdon, L.Gibson, J.Joshua, D.
10Jan-2017Busulfan is effective second-line therapy for older patients with Philadelphia-negative myeloproliferative neoplasms intolerant of or unresponsive to hydroxyureaForsyth, Cecily J Douglas, G.Harrison, C.N.Bennett, M.Stevenson, W.S.Hounsell, J.Ratnasingam, S.Ritchie, D.Ross, D.M.Grigg, A.
1124-Nov-2022Capturing the lived experiences of women with lymphoma in pregnancy: a qualitative studyMills, Georgia SDi Ciaccio, Pietro RTang, Catherine Chadwick, VerityMason, Kylie DCampbell, Belinda AShipton, Michael JShanavas, MohamedMorris, Kirk LGreenwood, MatthewLangfield, JennaKidson-Gerber, GiselleEslick, ReneeBadoux, XavierYannakou, Costas KGangatharan, Shane ABilmon, IanHamad, Nada
12Mar-2017A case-based discussion of clinical problems in the management of patients treated with ruxolitinib for myelofibrosisForsyth, Cecily J Ho, P.J.Bajel, A.Burbury, K.Dunlop, L.Durrant, S.Perkins, A.C.Ross, D.M.
137-Oct-2022Challenges associated with test dose pharmacokinetic predictions of high dose melphalan exposure in patients with multiple myelomaNath, Christa EllenGrigg, AndrewRosser, Sebastian P AEstell, JaneNewman, ElizabethTiley, Campbell Ramanathan, SundraHo, Shir JingLarsen, StephenGibson, JohnPresgrave, Peter Shaw, Peter JohnTrotman, Judith
14Apr-2019Changing incidence of myeloproliferative neoplasms in Australia, 2003-2014Forsyth, Cecily J Baade, P.D.Ross, D.M.Anderson, L.A.Fritschi, L.
1520-Dec-2022Clinical characteristics of Australian treatment-naïve patients with classical Hodgkin lymphoma from the lymphoma and related diseases registryNguyen, JamesWellard, CameronChung, ElizaCheah, Chan YDickinson, MichaelDoo, Nicole WongKeane, ColmTalaulikar, DiptiBerkahn, LeanneMorgan, SusanHamad, NadaCochrane, TaraJohnston, Anna MForsyth, Cecily J Opat, StephenBarraclough, AllisonMutsando, HowardRatnasingam, SumitaGiri, PratyushWood, Erica MMcQuilten, Zoe KHawkes, Eliza A
167-Mar-2023The clinical features, management and outcomes of lymphoma in pregnancy: A multicentre study by the Australasian Lymphoma AllianceDi Ciaccio, Pietro RMills, GeorgiaShipton, Michael JCampbell, BelindaGregory, GarethLangfield, JennaGreenwood, MatthewMcKeague, SeanShanavas, MohammadEslick, ReneeKidson-Gerber, GiselleSmallbone, PortiaTang, Catherine Morris, KirkBilmon, IanYannakou, CostasBadoux, XavierBerkahn, LeanneFarina, SergioMason, Kylie DMotum, PenelopeGoss, KathrynHamad, Nada
17Feb-2017Clinicopathological differences exist between CALR- and JAK2-mutated myeloproliferative neoplasms despite a similar molecular landscape: data from targeted next-generation sequencing in the diagnostic laboratory.Forsyth, Cecily J Agarwal, R.Blombery, P.McBean, M.Jones, K.Fellowes, A.Doig, K.Westerman, D.A.
18Dec-2001Collection and transport of samples for laboratory testing in von Willebrand's disease (VWD): time for a reappraisal?Forsyth, Cecily J Favaloro, E.J.Nair, S.C.
19Apr-2008Consensus Guidelines for 'Rainy Day' Autologous Stem Cell Harvests in New South WalesTrotman, J.Presgrave, Peter Kwan, Yiu Lam Tiley, Campbell Estell, J.Watson, A.M.O'Brian, T.A.Peters, D.
20Aug-2016Correlation of blood counts with vascular complications in essential thrombocythemia: analysis of the prospective PT1 cohortForsyth, Cecily J Campbell, P.J.MacLean, C.Beer, P.A.Buck, G.Wheatley, K.Kiladjian, J.J.Harrison, C.N.Green, A.R.
21Apr-2020Cutaneous multiple myelomaForsyth, Cecily J Jagger, Jacqueline Lai, S.
22May-2014Cyclical thrombocytosis, acquired von Willebrand syndrome and aggressive non-melanoma skin cancers are common in patients with Philadelphia-negative myeloproliferative neoplasms treated with hydroxyureaForsyth, Cecily J Verner, E.Grigg, A.
23Dec-2018The delayed diagnosis of myeloproliferative neoplasms is common and results in a high incidence of potentially preventable thrombotic complicationsForsyth, Cecily J Melville, K.Tiley, Campbell 
24Jan-2018Delayed-onset heparin-induced thrombocytopenia complicated by arterial and venous thrombosesForsyth, Cecily J HarrisonBalendran, S.Harrison, A.Morel-Kopp, M. C.Ward, C.
251994Development of a flow cytometric test for the detection of D-positive fetal cells after fetomaternal hemorrhage and a survey of the prevalence in D-negative womenForsyth, Cecily J Nelson, M.Popp, H.Horky, K.Gibson, J.
26Jan-2023Dietary intake of animal-based products and likelihood of follicular lymphoma and survival: A population-based family case-control studyOdutola, Michael Kvan Leeuwen, Marina TBassett, Julie KBruinsma, FionaTurner, JenniferSeymour, John FPrince, Henry MilesMilliken, Samuel THertzberg, MarkRoncolato, FernandoOpat, Stephen SLindeman, RobertTiley, Campbell Trotman, JudithVerner, EmmaHarvey, MichaelUnderhill, Craig RBenke, GezaGiles, Graham GVajdic, Claire M
27Feb-2012Distinguishing types 1 and 2M von Willebrand diseaseForsyth, Cecily J Favaloro, E.J.Koutts, J.
28Apr-2016Dysregulation of the intrinsic apoptotic pathway mediates megakaryocytic hyperplasia in myeloproliferative neoplasmsForsyth, Cecily J Malherbe, J.A.Fuller, K.A.Mirzai, B.Kavanagh, S.So, C.C.Ip, H.W.Guo, B.B.Howman, R.Erber, W.N.
29Oct-2020Efficacy and Safety of ABP 798: Results from the JASMINE Trial in Patients with Follicular Lymphoma in Comparison with Rituximab Reference ProductForsyth, Cecily J Niederwieser, D.Hamm, C.Cobb, P.Mo, M.Tucci, A.Hanes, V.Delwail, V.Hajek, R.Chien, D.
30Feb-2010Enrollment of Patients to Clinical Trials in Haematological Cancer in New South Wales: Current Status, Perceived Barriers and Opportunities for ImprovementMurray, P.Kerridge, Ian Tiley, Campbell Catanzariti, A.Welberry, H.Lean, C.Sinclair, S.Bishop, J.Bradstock, K.F.
31Feb-1995First trimester antigen typing of fetal red cells using a flow cytometric techniqueForsyth, Cecily J Nelson, M.Popp, H.Peat, B.Boogert, A.Gibson, J.
32Jan-2019Hereditary haemorrhagic telangiectasiaForsyth, Cecily J Mangkorntongsakul, Varitsara 
33Jul-2016High melphalan exposure is associated with improved overall survival in myeloma patients receiving high dose melphalan and autologous transplantationTiley, Campbell Nath, C.E.Trotman, J.Presgrave, P.Joshua, D.Kerridge, Ian Kwan, Y.L.Gurney, H.McLachlan, Andrew Earl, J.W.Nivison-Smith, I.Zeng, L.Shaw, P.J.
34Feb-1999Hodgkin's disease: a GP's guide to diagnosis and managementForsyth, Cecily J 
3526-Mar-2024How comparable are patient outcomes in the "real-world" with populations studied in pivotal AML trials?Tiong, Ing SooWall, MeaghanBajel, AshishKalro, AkashFleming, ShaunRoberts, Andrew WThiagarajah, NishaChua, Chong ChynLatimer, MayaYeung, DavidMarlton, PaulaJohnston, AmandaEnjeti, AnoopFong, Chun YewCull, GavinLarsen, StephenKennedy, GlenSchwarer, AnthonyKipp, DavidRamanathan, SundraVerner, EmmaTiley, Campbell Morris, EdwardHahn, UweMoore, JohnTaper, JohnPurtill, DuncanWarburton, PaulineStevenson, WilliamMurphy, Nicholas J Tan, PeterBeligaswatte, AshankaMutsando, HowardHertzberg, MarkShortt, JakeSzabo, FerencDunne, KarinWei, Andrew H
361991How do allogeneic bone marrow transplants cure leukaemia? The role of graft versus host diseaseTiley, Campbell Powles, R.Treleaven, J.Millar, J.Gordon-Smith, E.Findlay, M.Teo, C.Duncombe, A.Robinson, G.
37Jul-2012The Hsp90 inhibitor SNX-7081 synergizes with and restores sensitivity to fludarabine in chronic lymphocytic leukemia cells with lesions in the TP53 pathway: a potential treatment strategy for fludarabine refractory diseaseForsyth, Cecily J Best, O.G.Che, YSingh, N.Christopherson, R.I.Mulligan, S.P.
38Dec-1990Human recombinant GM-CSF in allogeneic bone-marrow transplantation for leukaemia: double-blind, placebo-controlled trialTiley, Campbell Powles, R.Smith, C.Milan, S.Treleaven, J.Millar, J.McElwain, T.Gordon-Smith, E.Miliken, S.
39Apr-2018Humoral immune failure defined by immunoglobulin class and immunoglobulin G subclass deficiency is associated with shorter treatment-free and overall survival in Chronic Lymphocytic LeukaemiaForsyth, Cecily J Crassini, K.R.Zhang, E.Balendran, S.Freeman, J.A.Best, O.G.Mackinlay, N.J.Han, P.Stevenson, W.S.Mulligan, S.P.
40May-2017Idarubicin dose escalation during consolidation therapy for adult Acute Myeloid LeukemiaTiley, Campbell Bradstock, K.F.Link, E.Di Iulio, J.Szer, J.Marlton, P.Wei, A.H.Enno, A.Schwarer, A.Lewis, I.D.D'Rozario, J.Coyle, L.Cull, G.Campbell, P.Leahy, M.F.Hahn, U.Cannell, P.Lowenthal, R.M.Moore, J.Cartwright, K.Cunningham, I.Taper, J.Grigg, A.Roberts, A.W.Benson, W.Hertzberg, M.Deveridge, S.Rowlings, P.Mills, A.K.Gill, Devinder S Bardy, P.Campbell, L.J.Seymour, J.F.
41Jun-2023Immunochemotherapy for life-threatening haematological malignancies in pregnancy: a systematic review of the literature and cross-sectional analysis of clinical trial eligibilityMills, Georgia SChadwick, VerityTang, Catherine Perram, JacintaAnderson, Mary AnnAnazodo, AntoinetteKidson-Gerber, GiselleShand, AntoniaLavee, OrlyWithers, BarbaraMilliken, SamDi Ciaccio, Pietro RHamad, Nada
42Jan-2013Immunoglobulin G subclass deficiency and infection risk in 150 patients with chronic lymphocytic leukemiaForsyth, Cecily J Freeman, J.A.Crassini, K.R.Best, O.G.Mackinlay, N.J.Han, P.Stevenson, W.S.Mulligan, S.P.
43May-2017The incidence and natural history of dasatinib complications in the treatment of chronic myeloid leukemiaForsyth, Cecily J Fox, L.Cummins, K.D.Costello, B.Yeung, D.Cleary, R.Tatarczuch, M.Burbury, K.Motorna, O.Shortt, J.Fleming, S.McQuillan, A.Schwarer, A.Harrup, R.Holmes, A.Ratnasingam, S.Chan, K.L.Hsu, W.H.Ashraf, A.Putt, F.Grigg, A.
44May-1997Management of acute vascular graft thrombosis associated with HIT syndrome: a case reportForsyth, Cecily J Wilson, M.McGahan, T.White, G.
45Sep-2020Melphalan exposure and outcome in obese and non-obese adults with myeloma. A study of pharmacokinetics and pharmacodynamicsTiley, Campbell Nath, C.E.Trotman, J.Nivison-Smith, I.Gurney, H.Zeng, L.Presgrave, P.Joshua, D.Kerridge, Ian McLachlan, Andrew Shaw, P.J.
4629-Jun-2022Monoclonal B-cell Lymphocytosis - a review of diagnostic criteria, biology, natural history, and clinical managementTang, Catherine Shen, YandongSoosapilla, AshaMulligan, Stephen P
47Dec-2019A multi-center randomized controlled trial to reduce unmet needs, depression, and anxiety among hematological cancer patients and their support personsTiley, Campbell Stevenson, W.Bryant, J.Watson, R.Sanson-Fisher, R.Oldmeadow, C.Henskens, F.Brown, C.Ramanathan, S.Enjeti, A.Guest, J.Tzelepis, F.Paul, C.D'Este, C.
48Aug-2013A multicenter, open-label, noncomparative screening study of Enzastaurin in adult patients with Non-Hodgkin LymphomasForsyth, Cecily J Gomez-Almaguer, D.Camargo, J.F.C.Eliadis, P.E.Crespo-Solis, E.Pereira, J.Gutierrez-Aguirre, C.H.Rivaz-Vera, S.Roberson, S.Lin, B.Smith, N.V.Hamid, O.
49Apr-2019The natural history of vascular and other complications in patients treated with nilotinib for chronic myeloid leukemiaForsyth, Cecily J Minson, A.G.Cummins, K.Fox, L.Costello, B.Yeung, D.Cleary, R.Tatarczuch, M.Burbury, K.Motorna, O.Shortt, J.Fleming, S.McQuillan, A.Schwarer, A.Harrup, R.Holmes, A.Ratnasingam, S.Chan, K.L.Hsu, W.H.Ashraf, A.Putt, F.Grigg, A.
50Oct-2015The novel Hsp-90 inhibitor SNX7081 is significantly more potent than 17-AAG against primary CLL cells and a range of haematological cell lines, irrespective of lesions in the TP53 pathwayForsyth, Cecily J Best, O.G.Singh, N.Mulligan, S.P.
51Oct-2023Occupational exposure to extremely low-frequency magnetic fields and follicular lymphoma risk: a family case-control studyOdutola, Michael Kvan Leeuwen, Marina TBruinsma, Fiona JBenke, GezaTurner, Michelle CTrotman, JudithTurner, JenniferSeymour, John FPrince, H MilesMilliken, Samuel TTiley, Campbell Hertzberg, MarkRoncolato, FernandoOpat, StephenLindeman, RobertVerner, EmmaUnderhill, Craig RCardis, ElisabethGiles, GrahamVajdic, Claire M
52Feb-2015The oral iron chelator deferasirox inhibits NF-kappaB mediated gene expression without impacting on proximal activation: implications for myelodysplasia and aplastic anaemiaForsyth, Cecily J Banerjee, A.Mifsud, N. A.Bird, R.Szer, J.Tam, C.Kellner, S.Grigg, A.Motum, P.Bentley, M.Opat, S.Grigoriadis, G.
53Oct-1995Oral L-arginine inhibits platelet aggregation but does not enhance endothelium-dependent dilation in healthy young menForsyth, Cecily J Adams, M.R.Jessup, W.Robinson, J.Celermajer, D.S.
54Sep-2019Outpatient rituximab, ifosfamide, etoposide (R-IE) in patients older than 60 years with relapsed or refractory diffuse large B-cell lymphoma who are not candidates for stem cell transplantationForsyth, Cecily J Joshi, M.Taper, J.Rowlings, P.Campbell, P.Crispin, P.Harvey, M.Underhill, C.Bayley, A.Byth, K.Huang, G.Hertzberg, M.
555-Mar-2023Painless progressive mononeuritis multiplex secondary to AML associated neuroleukemiosisNagaratnam, Sai Harinesan, NimalanWijesinghe, RajivWong-Doo, NicoleLyons, Alison Morris, KatrinaTriplett, James 
5614-Jun-2022Paraprotein associated heparin resistance during cardiopulmonary bypassKhuong, Jacqueline NForsyth, Cecily J Manuel, LucyKingsford-Smith, KateSrivastava, ArpitBassin, Levi
57Jul-2014Perioperative and peripartum prevention of venous thromboembolism in patients with hereditary antithrombin deficiency using recombinant antithrombin therapyForsyth, Cecily J Paidas, M.J.Quere, I.Rodger, M.
58Jun-2012A Phase II Study of Risk-Adapted Intravenous Melphalan in patients with AL AmyloidosisMollee, P.Tiley, Campbell Cunningham, I.Moore, J.Prince, M.Cannell, P.Gibbons, S.Tate, J.Paul, S.Mar Fan, H.Gill, Devinder S 
591-Mar-2024Phase II trials of zilucoplan in paroxysmal nocturnal hemoglobinuriaKulasekararaj, Austin GLehtinen, Anna-ElinaForsyth, Cecily Gandhi, ShreyansGriffin, MoragKörper, SixtenMikala, GaborMuus, PetraOvergaard, UlrikPatriquin, Christopher JPullon, HumphreyShen, Yu-MinSpearing, RuthSzer, JeffDe la Borderie, GuillemetteDuda, Petra WFarzaneh-Far, RaminRagunathan, SharanSayegh, Camil EVadysirisack, Douangsone DSchrezenmeier, Hubert
60May-2010Population Pharmacokinetics of Melphalan in Patients with Multiple Myeloma Undergoing High Dose TherapyNath, C.E.Shaw, P.J.Trotman, J.Zeng, L.Duffull, S.Hegarty, G.McLachlan, Andrew Gurney, H.Kerridge, Ian Kwan, Yiu Lam Presgrave, P.Tiley, Campbell Joshua, D.Earl, J.W.
6113-Oct-2023A population-based family case-control study of sun exposure and follicular lymphoma riskOdutola, Michael Kvan Leeuwen, Marina TBruinsma, FionaTurner, JenniferHertzberg, MarkSeymour, John FPrince, H MilesTrotman, JudithVerner, EmmaRoncolato, FernandoOpat, StephenLindeman, RobertTiley, Campbell Milliken, Samuel TUnderhill, Craig RBenke, GezaGiles, Graham GVajdic, Claire M
62Aug-2011Positron emission tomography-computed tomography (PET-CT) after induction therapy is highly predictive of patient outcome in follicular lymphoma: analysis of PET-CT in a subset of PRIMA trial participantsForsyth, Cecily J Trotman, J.Fournier, MLamy, T.Seymour, J.F.Sonet, A.Janikova, A.Shpilberg, O.Gyan, E.Tilly, H.Estell, J.Decaudin, D.Fabiani, B.Gabarre, J.Salles, B.Van Den Neste, E.Canioni, D.Garin, E.Fulham, M.Vander Borght, T.Salles, G.
63Jul-2021Proteasome inhibitor-induced coronary vasospasm in multiple myeloma: A case reportRogers, James Forsyth, Cecily J Ford, Tom Mikhail, Philopatir 
641995Quantifying the loss of ABO antigenicity in a patient with acute myeloid leukemia by flow cytometric analysisForsyth, Cecily J Popp, H.J.Nelson, M.Falson, M.Kronenberg, H.
651996A quick differentiation between iron deficiency and thalassaemia syndromeForsyth, Cecily J Yuen, S.Brown, R.Zarkos, K.
66May-2017Raccoon eyes in systemic light chain amyloidosisForsyth, Cecily J Tiley, Campbell 
67Dec-1994Rapid detection of Rh(D)- or K-positive fetal red cells in chorion villus samples by a flow cytometric techniqueForsyth, Cecily J Nelson, M.Popp, H.Gibson, J.
68Sep-1996Rapid quantitation of mixed red cell populations using flow cytometryForsyth, Cecily J Nelson, M.Popp, H.Gibson, J.
69Nov-2018Recommendations for the use of pegylated interferon-alpha in the treatment of classical myeloproliferative neoplasmsForsyth, Cecily J Chan, Wai-Hoong Grigg, A.Cook, N.C.Lane, S.W.Burbury, K.Perkins, A.C.Ross, D.M.
70Mar-1995Severe hemolysis due to anti-D in a D-negative recipient of an orthotopic liver transplantForsyth, Cecily J Popp, H.Kronenberg, H.McCaughan, G.
71Nov-1992Severe vascular adverse effects with thrombocytopenia and renal failure following emetogenic chemotherapy and ondansetronForsyth, Cecily J Coates, A.S.Childs, A.Cox, K.Joshua, D.E.McNeil, E.Grygiel, J.J.
725-Jul-2023Somatic mutational landscape of hereditary hematopoietic malignancies caused by germ line RUNX1, GATA2, and DDX41 variantsHoman, Claire CDrazer, Michael WYu, KaiLawrence, David MichaelFeng, JinghuaArriola-Martinez, Luis AlbertoPozsgai, Matthew JMcNeely, Kelsey EHa, Thuong ThiVenugopal, ParvathyArts, PeerKing-Smith, SarahCheah, Jesse JcArmstrong, MarkWang, PaulBödör, CsabaCantor, Alan BCazzola, MarioDegelman, Erin SDiNardo, Courtney DDuployez, NicolasFavier, RémiFröhling, StefanRio-Machin, AnaKlco, Jeffery MKrämer, AlwinKurokawa, MineoLee, JoanneMalcovati, LucaMorgan, Neil VGeorges, NatsoulisOwen, CarolynPatel, Keyur PPreudhomme, ClaudeRaslova, HanaRienhoff, Hugh YoungRipperger, TimSchulte, Rachael RTawana, KiranVelloso, ElviraBenedict, YanKim, Erika Mijin KwonSood, RamanHsu, Amy PHolland, Steven MPhillips, KerryPoplawski, NicolaBabic, MilenaWei, Andrew HForsyth, Cecily J Mar Fan, HelenLewis, IanCooney, Julian PSusman, RachelFox, Lucy CBlombery, PiersSinghal, DeepakHiwase, Devendra KPhipson, BelindaSchreiber, Andreas WHahn, Christopher NScott, Hamish SLiu, Paul PGodley, Lucy ABrown, Anna L
737-Dec-2023Sorafenib plus intensive chemotherapy in newly diagnosed FLT3-ITD AML: a randomized, placebo-controlled study by the ALLGLoo, SunRoberts, Andrew WAnstee, Natasha SKennedy, Glen AHe, SimonSchwarer, Anthony PEnjeti, Anoop KD'Rozario, JamesMarlton, PaulaBilmon, Ian ATaper, JohnCull, GavinTiley, Campbell Verner, EmmaHahn, UweHiwase, Devendra KIland, Harry JMurphy, NickRamanathan, SundraReynolds, JohnOng, Doen MingTiong, Ing SooWall, MeaghanMurray, MichaelRawling, TristanLeadbetter, JoannaRowley, LeesaLatimer, MayaYuen, SamTing, Stephen BFong, Chun YewMorris, KirkBajel, AshishSeymour, John FLevis, Mark JWei, Andrew H
74Feb-1996Thalidomide responsive chronic pulmonary GVHDForsyth, Cecily J Cremer, P.D.Torzillo, P.Iland, H.J.Young, G.A.
75Jun-1989Therapy-induced drug resistance in a human leukemia line (LALW-2). A clinically relevant modelTiley, Campbell White, L.Haber, M.Brian, M.J.Norris, M.D.Trickett, A.Sosula, L.Stewart, B.W.
76Feb-2015TIDEL-II: first-line use of imatinib in CML with early switch to nilotinib for failure to achieve time-dependent molecular targets.Yeung, D.Osborn, M.White, D.Branford, S.Braley, J.Herschtal, A.Kornhauser, M.Issa, S.Hiwase, D.Hertzberg, M.Schwarer, A.Filshie, R.Arthur, C.Kwan, Y.L.Trotman, J.Forsyth, Cecily J Taper, J.Ross, D.M.Beresford, J.Tam, C.Mills, A.K.Grigg, A.Hughes, T.
771995Transfusion of patients with haemoglobinopathiesForsyth, Cecily J Chisholm, J.Popp, H.
781991Treatment of acute graft versus host disease with a murine monoclonal antibody to the IL-2 receptorTiley, Campbell Powles, R.Teo, C.P.Treleaven, J.Findlay, M.Hewetson, M.
79Feb-2020Two monogenic disorders masquerading as one: severe congenital neutropenia with monocytosis and non-syndromic sensorineural hearing lossForsyth, Cecily J Venugopal, P.Gagliardi, L.Feng, J.Phillips, K.Babic, M.Poplawski, N.K.Rienhoff, H.Y.,Jr.Schreiber, A.W.Hahn, C.N.Brown, A.L.Scott, H.S.
80May-2017Upfront lower dose lenalidomide is less toxic and does not compromise efficacy for vulnerable patients with relapsed refractory multiple myeloma: final analysis of the phase II RevLite studyForsyth, Cecily J Quach, H.Fernyhough, L.Henderson, R.Corbett, G.Baker, B.Browett, P.Blacklock, H.Underhill, C.Cannell, P.Trotman, J.Neylon, A.Harrison, S.Link, E.Swern, A.Cowan, L.Dimopoulos, M.A.Miles Prince, H.
81Sep-2015Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: a non-randomised phase 2 trialTiley, Campbell Iland, H.J.Collins, M.Bradstock, K.F.Supple, S.G.Catalano, A.Hertzberg, M.Browett, P.Grigg, A.Firkin, F.Campbell, L.J.Hugman, A.Reynolds, J.Di Iulio, J.Taylor, K.Filshie, R.Seldon, M.Taper, J.Szer, J.Moore, J.Bashford, J.Seymour, J.F.
8222-Nov-2023Variability of bone marrow biopsy reporting affects accuracy of diagnosis of myeloproliferative neoplasms: data from the ALLG MPN01 registryNg, Wei YangErber, Wendy NGrigg, AndrewDunne, KarinPerkins, AndrewForsyth, Cecily Ross, David M
83Apr-2012When should iron chelation therapy be considered in patients with myelodysplasia and other bone marrow failure syndromes with iron overload?Forsyth, Cecily J Bird, R.Kenealy, M.Wellwood, J.Leahy, M.F.Seymour, J.F.To, L.B.